Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product revenue guidance in six months.
Nasdaq15d
March 14th Options Now Available For Moderna (MRNA)
Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...
Hosted on MSN1mon
Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken
sentiment for Moderna plunged to ‘extremely bearish’ levels, hitting levels last seen in February 2024. Meanwhile, soaring message volume drove the ticker into the top three trending symbols ...
Nasdaq16d
Decoding Moderna's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 31 unusual trades. Delving into the details, we found 51% of ...